Servicios Personalizados
Articulo
Indicadores
Links relacionados
Bookmark
Revista médica de Chile
versión impresa ISSN 0034-9887
Resumen
KAUFFMANN Q, Ronald; OROZCO B, Rodrigo y VENEGAS G, Juan Carlos. Severe hyperkalemia associated to the use of losartan and spironolactone: Case report. Rev. méd. Chile [online]. 2005, vol.133, n.8, pp. 947-952. ISSN 0034-9887. doi: 10.4067/S0034-98872005000800012.
Hyperkalemia is a complications of the use of angiotensin converting enzyme inhibitors, angiotensin receptor antagonists and aldosterone antagonists. These drugs are commonly used for the treatment of hypertension and cardiac failure. We report a 84 year-old female treated with losartan 50 mg/day and spironolactone 25 mg/day that presented with a hyperkalemia of 8.4 mEq/l and bradicardia, drowsiness and respiratory depression. She required hemodialysis and ventilatory assistance. She was discharged in good conditions five days after admission
Palabras clave : Hyperkalemia; Losartan; Spironolactone.











